Clinical Trials Browser

Phase 3 × Not yet recruiting × pyrotinib × Clear all

NCT05841381 2023-05-03

Adjuvant Study of Pyrotinib in Combination With Trastuzumab in HER2 Positive Invasive Breast Cancer

Phase 3 Not yet recruiting

Breast Neoplasms

NCT04973319 2021-07-22

Trastuzumab Combined With Pertuzumab for Adjuvant Treatment of Breast Cancer After Neoadjuvant Therapy

Phase 3 Not yet recruiting

Breast Neoplasms